Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -110.55%-438.53M | ---- | -7.14%-208.28M | ---- | -126.66%-194.4M | ---- | 38.63%729.14M | ---- | 84.70%525.98M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -22.76%-44.84M | ---- | 17.95%-36.53M | ---- | -27.96%-44.52M | ---- | -10.01%-34.79M | ---- | -21.47%-31.63M |
| Impairment and provisions: | ---- | -37.32%34.59M | ---- | 138.43%55.19M | ---- | -191.47%-143.6M | ---- | 2,893.38%156.99M | ---- | 73.72%-5.62M |
| -Impairmen of inventory (reversal) | ---- | -59.11%17.85M | ---- | 130.22%43.67M | ---- | -191.67%-144.52M | ---- | 1,473.78%157.66M | ---- | 60.24%-11.48M |
| -Impairment of trade receivables (reversal) | ---- | 45.27%16.74M | ---- | 1,149.57%11.52M | ---- | 238.23%922K | ---- | -111.39%-667K | ---- | -21.67%5.86M |
| Asset sale loss (gain): | ---- | 3.36%707K | ---- | 43.40%684K | ---- | -80.02%477K | ---- | 870.33%2.39M | ---- | -38.65%246K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 3.36%707K | ---- | 43.40%684K | ---- | 8.16%477K | ---- | 79.27%441K | ---- | -38.65%246K |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.95M | ---- | ---- |
| Depreciation and amortization: | ---- | 3.01%451.59M | ---- | 3.99%438.4M | ---- | 1.50%421.58M | ---- | 53.21%415.36M | ---- | 11.97%271.11M |
| -Depreciation | ---- | 3.01%451.59M | ---- | 3.99%438.4M | ---- | 1.50%421.58M | ---- | --415.36M | ---- | ---- |
| -Amortization of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 27.21%3.07M |
| -Other depreciation and amortization | ---- | -2.53%-12.91M | ---- | -20.02%-12.59M | ---- | -8.56%-10.49M | ---- | -7.49%-9.66M | ---- | -29.52%-8.99M |
| Financial expense | ---- | 4.88%286.46M | ---- | 0.71%273.13M | ---- | 0.75%271.2M | ---- | 22.67%269.19M | ---- | -3.56%219.45M |
| Special items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -8.57%8.24M |
| Adjustment items | ---- | -2.53%-12.91M | ---- | -20.02%-12.59M | ---- | -8.56%-10.49M | ---- | -7.49%-9.66M | ---- | -29.52%-8.99M |
| Operating profit before the change of operating capital | ---- | -45.67%277.08M | ---- | 69.86%510.01M | ---- | -80.36%300.25M | ---- | 56.17%1.53B | ---- | 37.96%978.78M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 123.68%113.2M | ---- | -236.17%-477.99M | ---- | 154.39%351.03M | ---- | -46.22%-645.33M | ---- | -569.10%-441.34M |
| Accounts receivable (increase)decrease | ---- | 645.65%196.08M | ---- | 83.58%-35.94M | ---- | 32.38%-218.88M | ---- | -183.40%-323.66M | ---- | -170.92%-114.21M |
| Accounts payable increase (decrease) | ---- | -22.81%252.04M | ---- | 75.76%326.5M | ---- | 259.18%185.77M | ---- | 139.33%51.72M | ---- | 87.48%-131.5M |
| Special items for working capital changes | ---- | -567.67%-134.2M | ---- | 12.79%28.7M | ---- | -88.74%25.44M | ---- | -27.40%225.96M | ---- | -50.48%311.27M |
| Cash from business operations | 646.89%254.96M | 100.47%704.19M | 88.13%-46.62M | -45.42%351.28M | -99.14%-392.6M | -23.13%643.61M | -165.21%-197.15M | 38.86%837.3M | 188.98%302.33M | 57.52%603M |
| Other taxs | 12.35%-9.35M | 56.27%-22.58M | 75.69%-10.67M | 61.94%-51.63M | 67.28%-43.86M | 16.79%-135.66M | -27.97%-134.06M | -155.78%-163.03M | -84.70%-104.76M | 25.04%-63.74M |
| Interest received - operating | 23.97%26.7M | 12.01%46.4M | -33.34%21.54M | 3.82%41.42M | 21.19%32.3M | 21.21%39.9M | 46.73%26.66M | 11.59%32.92M | 23.99%18.17M | -33.33%29.5M |
| Interest paid - operating | 4.67%-137.11M | -5.39%-288.55M | 5.13%-143.83M | 0.65%-273.79M | -40.16%-151.62M | -1.71%-275.57M | 16.64%-108.17M | -18.95%-270.95M | -16.21%-129.76M | -1.66%-227.78M |
| Net cash from operations | 175.28%135.2M | 553.18%439.46M | 67.69%-179.58M | -75.29%67.28M | -34.66%-555.77M | -37.59%272.28M | -580.01%-412.72M | 27.94%436.24M | 275.11%85.98M | 189.08%340.97M |
| Cash flow from investment activities | ||||||||||
| Sale of fixed assets | ---- | -70.04%432K | ---- | -6.36%1.44M | ---- | 160.58%1.54M | ---- | -58.47%591K | ---- | 152.30%1.42M |
| Purchase of fixed assets | 66.66%-89.28M | 30.76%-442.37M | 9.58%-267.77M | 1.99%-638.89M | 0.57%-296.15M | -5.60%-651.84M | -1.34%-297.85M | -9.18%-617.24M | -25.04%-293.92M | -0.69%-565.34M |
| Selling intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --34.87M | ---- | ---- |
| Purchase of intangible assets | ---- | 93.68%-1.75M | ---- | -295.51%-27.66M | ---- | 90.19%-6.99M | ---- | -433.15%-71.3M | ---- | 69.72%-13.37M |
| Other items in the investment business | -100.38%-32.02M | 6.57%11.35M | 64.51%-15.98M | 31.08%10.65M | -784.56%-45.04M | -1.73%8.12M | 183.48%6.58M | -17.50%8.27M | -485.38%-7.88M | -78.98%10.02M |
| Net cash from investment operations | 57.25%-121.31M | 33.94%-432.33M | 16.83%-283.75M | -0.82%-654.46M | -17.14%-341.18M | -0.68%-649.17M | 3.49%-291.27M | -13.67%-644.81M | -29.52%-301.8M | -1.77%-567.27M |
| Net cash before financing | 103.00%13.89M | 101.21%7.13M | 48.34%-463.33M | -55.80%-587.18M | -27.41%-896.96M | -80.70%-376.89M | -226.21%-704M | 7.83%-208.58M | 23.50%-215.81M | 48.50%-226.3M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 49.31%4.34B | 36.29%15.43B | 63.41%2.91B | 11.20%11.32B | -14.51%1.78B | -2.94%10.18B | 18.51%2.08B | 1.55%10.49B | 70.60%1.76B | 68.17%10.33B |
| Refund | ---- | -43.58%-11B | ---- | -15.58%-7.66B | ---- | 13.72%-6.63B | ---- | 3.02%-7.68B | ---- | -73.41%-7.92B |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --54.48M | ---- | ---- |
| Dividends paid - financing | ---- | -5.25%-21.05M | 0.00%-20M | 78.70%-20M | 68.77%-20M | 29.24%-93.88M | 9.97%-64.04M | -209.95%-132.66M | -73.28%-71.13M | 45.62%-42.8M |
| Absorb investment income | ---- | ---- | ---- | --4.15M | --4.14M | ---- | ---- | --35.71M | ---- | ---- |
| Pledged bank deposit (increase) decrease | ---- | -42.30%-4.52B | ---- | -7.20%-3.18B | ---- | -16.86%-2.96B | ---- | -11.09%-2.54B | ---- | -85.94%-2.28B |
| Other items of the financing business | -73.69%-4.12B | 84.32%-3M | -138.56%-2.37B | -113.16%-19.14M | 17.17%-994.57M | 475.73%145.38M | 0.57%-1.2B | -72.98%25.25M | -74.62%-1.21B | -51.73%93.46M |
| Net cash from financing operations | -57.32%219.58M | -126.73%-118.77M | -33.06%514.54M | -30.12%444.39M | -5.84%768.64M | 155.49%635.9M | 71.01%816.28M | 44.96%248.89M | 60.87%477.34M | -62.69%171.69M |
| Effect of rate | ---- | -82.45%218K | ---- | -81.32%1.24M | ---- | 388.08%6.65M | ---- | 42.52%-2.31M | ---- | -491.33%-4.02M |
| Net Cash | 355.95%233.47M | 21.82%-111.64M | 139.91%51.21M | -155.13%-142.79M | -214.27%-128.32M | 542.47%259.01M | -57.06%112.29M | 173.83%40.32M | 1,690.52%261.52M | -362.81%-54.6M |
| Begining period cash | -42.00%153.89M | -34.79%265.31M | -34.79%265.31M | 188.15%406.86M | 188.15%406.86M | 36.83%141.2M | 36.83%141.2M | -36.23%103.19M | -36.23%103.19M | 15.57%161.81M |
| Cash at the end | 22.38%387.36M | -42.00%153.89M | 13.63%316.52M | -34.79%265.31M | 9.89%278.54M | 188.15%406.86M | -30.50%253.48M | 36.83%141.2M | 106.74%364.71M | -36.23%103.19M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.